Calithera Biosciences, Inc.
Calithera Biosciences, Inc.（CALA）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · CALA · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
1
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Calithera Biosciences, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
CALA 季度内部人买卖趋势
CALA 内幕交易卖出 · CALA 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
近期内幕交易记录
CALA 高管卖出股份 · CALA 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jan 27, 2023 | PAKIANATHAN DEEPIKA Director | Sale | 1,172 | $452 | Form 4 |
| Jan 23, 2023 | Sjogren Eric SR. VP, DRUG DISCOVERY | Other | 279 | $124 | Form 4 |
| Jan 23, 2023 | Kuriakose Emil CHIEF MEDICAL OFFICER | Other | 79 | $35 | Form 4 |
| Jan 23, 2023 | Molineaux Susan PRESIDENT & CEO | Other | 526 | $235 | Form 4 |
| Jan 23, 2023 | Wong Stephanie See Remarks | Other | 317 | $141 | Form 4 |
| Jan 23, 2023 | Molineaux Christopher SR. VP, DEVELOPMENT | Other | 217 | $97 | Form 4 |
| Jan 21, 2022 | Parlati Francesco SR. VP, RESEARCH | Other | 4,794 | $2K | Form 4 |
| Jan 21, 2022 | Wong Stephanie See Remarks | Other | 5,586 | $3K | Form 4 |
| Jan 21, 2022 | Sjogren Eric SR. VP, DRUG DISCOVERY | Other | 4,794 | $2K | Form 4 |
| Jan 21, 2022 | Kuriakose Emil CHIEF MEDICAL OFFICER | Other | 666 | $327 | Form 4 |
| Jan 4, 2022 | Parlati Francesco SR. VP, RESEARCH | Other | 18,077 | $12K | Form 4 |
| Jan 4, 2022 | Kuriakose Emil CHIEF MEDICAL OFFICER | Other | 3,855 | $3K | Form 4 |
| Jan 4, 2022 | Sjogren Eric SR. VP, DRUG DISCOVERY | Other | 18,077 | $12K | Form 4 |
| Jan 4, 2022 | Wong Stephanie See Remarks | Other | 18,077 | $12K | Form 4 |
| Nov 10, 2021 | Orford Keith Director | Sale | 30,000 | $26K | Form 4 |
| Nov 11, 2021 | Orford Keith Director | Sale | 48,190 | $42K | Form 4 |
| Nov 10, 2021 | Molineaux Susan PRESIDENT & CEO · Director | Purchase | 100,000 | $85K | Form 4 |
| Nov 10, 2021 | DRACHMAN JONATHAN G Director | Purchase | 200,000 | $172K | Form 4 |
| Nov 10, 2021 | Molineaux Christopher SR. VP, DEVELOPMENT | Purchase | 100,000 | $85K | Form 4 |
| Nov 5, 2021 | Orford Keith Director | Award | 30,000 | — | Form 4 |
| Nov 9, 2021 | Orford Keith Director | Sale | 51,810 | $44K | Form 4 |
| Nov 5, 2021 | Molineaux Christopher SR. VP, DEVELOPMENT | Award | 12,000 | — | Form 4 |
| Nov 5, 2021 | Sjogren Eric SR. VP, DRUG DISCOVERY | Award | 30,000 | — | Form 4 |
| Nov 8, 2021 | Sjogren Eric SR. VP, DRUG DISCOVERY | Other | 15,566 | $14K | Form 4 |
| Nov 5, 2021 | Wong Stephanie See Remarks | Award | 30,000 | — | Form 4 |
Molineaux Susan
PRESIDENT & CEO · Director
日期
Nov 10
股数
100,000
均价
$0.85
总金额
$85K
Molineaux Christopher
SR. VP, DEVELOPMENT
日期
Nov 10
股数
100,000
均价
$0.85
总金额
$85K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 CALA 内幕交易
CALA 内幕交易
Calithera Biosciences, Inc.（CALA）内幕交易数据来源于公司内部人（包括CALA）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。CALA内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Calithera Biosciences, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
CALA 内幕交易 · 5个问题Calithera Biosciences, Inc.（CALA）的内部人包括高管和董事，如CALA等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026